Detection of carotid artery plaque in the blood flow due to new ultrasonic inspection method that does not use a contrast agent
Phase 1
- Conditions
- Carotid atherosclerosis
- Registration Number
- JPRN-UMIN000023264
- Lead Sponsor
- Tokushima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
Not obtained consent to the person or persons Daidaku Contraindication cases of contrast-enhanced ultrasonography enforcement (patient patient with a history of hypersensitivity to components of this drug, to eggs or egg products are allergic)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method indicator of the carotid artery echocardiography plaque size, plaque brightness, plaque surface, blood flow degree, functional assessment items that are recommended in the guidelines, such as stenosis rate. contrast-enhanced ultrasonography assess the presence or absence of plaque in the blood flow signals in the contrast-enhanced ultrasonography. iPlaque tissue characterization evaluation of carotid artery plaque. CEA specimen compare the plaque within the blood flow at the resected specimen and each technique.
- Secondary Outcome Measures
Name Time Method Patients Background and history medical record ID, age, sex, body weight, the presence or absence of complications, history of allergy, history Cardiovascular disease valvular disease, cardiomyopathy, ischemic heart disease, arteriosclerosis obliterans, vasculitis, other Cardiovascular factors high blood pressure, diabetes, dyslipidemia, taste history oral medicine ACE, ARB, CCB, B-blocker, diuretics, statins, other. clinical examination blood count the number of white blood cells, red blood cell count, hemoglobin, platelet count, etc. Biochemistry hepatobiliary system, kidney, function indicator of the pancreas